Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients (SHIVERING 2)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms SHIVERING 2
- 07 Sep 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
- 07 Sep 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016.
- 07 Sep 2016 Status changed from recruiting to active, no longer recruiting.